onabotulinumtoxinA

Botox Cosmetic onabotulinumtoxinA celebrates two decades

by

BOTOX Cosmetic (onabotulinumtoxinA) Celebrates 20 Years Since First U.S. FDA Approval. Allergan Aesthetics, an AbbVie company announced the celebration of a milestone moment for BOTOX Cosmetic (onabotulinumtoxinA). April 15, 2022, marked 20 years since the U.S. Food and Drug Administration (FDA) first approved the product to temporarily improve the look of moderate to severe glabellar … Read more

BOTOX Cosmetic: 10-Year Anniversary of FDA Approval

by

BOTOX Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval. BOTOX Cosmetic is a prescription medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in people 18 to 65 years of age for a short period of time … Read more